Fairmount Funds Management LLC
- SEC CIK
- 0001802528
- Latest filing
- Aug 14, 2026
Holdings in Q2 2021
Holdings as of Jun 30, 2021, filed Aug 13, 2021. Long positions only; changes compare share counts with Q1 2021.
- Positions
- 19
- −2 vs. Q1 2021
- Portfolio value
- $243.2M
- +$5.99M (+2.5%) vs. Q1 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| INSMINSMED Inc | COM PAR $.01 | 1,283,887 | $36.5M | 15.0% | +322,090+33.5% | Added | History |
| ZGNXZogenix, Inc. | COM NEW | 1,970,259 | $34.0M | 14.0% | +565,000+40.2% | Added | History |
| AXSMAxsome Therapeutics, Inc. | COM | 312,598 | $21.1M | 8.7% | +61,000+24.2% | Added | History |
| ARGXArgenx SE | SPONSORED ADR | 69,144 | $20.8M | 8.6% | +17,694+34.4% | Added | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 505,890 | $13.2M | 5.4% | −60,000−10.6% | Reduced | History |
| TILInstil Bio, Inc. | COM | 673,905 | $13.0M | 5.4% | +123,905+22.5% | Added | History |
| ALLKAllakos Inc. | COM | 152,162 | $13.0M | 5.3% | +4,500+3.0% | Added | History |
| COGTCogent Biosciences, Inc. | COM | 1,558,975 | $12.6M | 5.2% | 00.0% | Unchanged | History |
| AMRNAmarin Corp PLC | SPONS ADR NEW | 2,533,237 | $11.1M | 4.6% | +925,000+57.5% | Added | History |
| ACADAcadia Pharmaceuticals Inc | COM | 423,817 | $10.3M | 4.2% | −8,500−2.0% | Reduced | History |
| Therapeutics Acquisition Cor88339T103 | COM CL A | 864,214 | $8.88M | 3.6% | +814,214+1,628.4% | Added | – |
| Trillium Therapeutics Inc.89620X506 | COM NEW | 896,281 | $8.69M | 3.6% | −426,900−32.3% | Reduced | – |
| Catabasis Pharmaceuticals IN14875P206 | COM NEW | 4,092,166 | $8.63M | 3.5% | +4,039,000+7,597.0% | Added | – |
| FOLDAmicus Therapeutics, Inc. | COM | 888,980 | $8.57M | 3.5% | +100,000+12.7% | Added | History |
| ENTAEnanta Pharmaceuticals Inc | COM | 178,058 | $7.84M | 3.2% | +6,911+4.0% | Added | History |
| GBTGlobal Blood Therapeutics, Inc. | COM | 210,000 | $7.35M | 3.0% | +35,000+20.0% | Added | History |
| KROSKeros Therapeutics, Inc. | COM | 149,333 | $6.34M | 2.6% | +40,000+36.6% | Added | History |
| VRDNViridian Therapeutics, Inc. | COM | 35,092 | $642.0K | 0.3% | 00.0% | Unchanged | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 83,944 | $549.0K | 0.2% | 00.0% | Unchanged | History |
Sold out since Q1 2021 (2)
Positions held at the end of Q1 2021 that are gone from this filing.